logo

For the Inventor, By the Inventor

Charenton le Pont, France

Francedillaois Audiau

USPTO Granted Patents = 8

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal8 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents

Years Active: 1996-2000

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6057454 - 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates (2000-05-02),
2. 5922716 - 5H-indeno�1,2-b!pyrazine-2,3-dione derivatives, their preparation and (1999-07-13),
3. 5902803 - 5H,10H-imidazo�1,2-a!indeno�1,2-e!pyrazin-4-one derivatives, preparation (1999-05-11),
4. 5789406 - Indeno�1,2-E!pyrazine-4-ones, their preparation and the medicaments (1998-08-04),
5. 5777114 - Spiro�heterocycle-imidazo�1,2-a!indeno�1,2-e!pyrazine!-4'-ones, (1998-07-07),
6. 5726175 - Imidazo�1,2-A!indeno�1,2-E!pyrazine-2-carboxylic acid derivatives, (1998-03-10),
7. 5677306 - Derivatives of 5H, 10H-imidazo�1, 2-a!indeno�1,2-e!pyrazin-4-one, (1997-10-14),
8. 5567822 - Process for the preparation of 2-amino-7-nitrobenzo-thiazoles (1996-10-22),

Title: Francedillaois Audiau: Innovator in Pharmacological Compounds

Introduction

Francedillaois Audiau is a notable inventor based in Charenton le Pont, France. He has made significant contributions to the field of pharmacology, holding a total of 8 patents. His work focuses on developing compounds with valuable pharmacological properties.

Latest Patents

One of Audiau's latest patents involves the synthesis of 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates. This compound, represented by a specific formula, includes various radicals that can be utilized to prepare other compounds with significant pharmacological effects. These compounds act as antagonists of the AMPA receptor and are also non-competitive antagonists of the NMDA receptor, making them important in the study of neurological functions.

Career Highlights

Francedillaois Audiau has been associated with Rhone-Poulenc Rorer S.A., where he has contributed to various innovative projects. His expertise in pharmacological compounds has positioned him as a key figure in his field.

Collaborations

Throughout his career, Audiau has collaborated with notable colleagues such as Patrick Jimonet and Serge Mignani. These partnerships have further enhanced his research and development efforts in pharmacology.

Conclusion

Francedillaois Audiau's work in developing pharmacological compounds showcases his innovative spirit and dedication to advancing medical science. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…